MY ACCOUNT | NEWSLETTER |

Worldwide animal vaccine market to reach nearly $14B by 2028


Market research firm, Allied Market Research, forecasts the global animal vaccines market to reach $13.78 billion by 2028. The market was valued at $9.09 billion in 2020. The increase marks a 5.3% CAGR between 2021 and 2028.

North America led the increase with the largest market share (more than 1/3) in 2020. Future growth is anticipated based on current increase in animal diseases, increased number of pets, and interest in pet insurance. At the same time, an uptick in the price of milk and meat and impact on the health of animal vaccines may temper the market growth. 

Attenuated vaccines captured the largest market (more than 1/3) share in 2020 and is expected to continue, while DNA vaccines are expected to grow at a CAGR of 8.2% from 2021 to 2028. In the global vaccine market, livestock animals held the largest share at about 2/3 in 2020, and is expected to continue to lead in the next period. However, the companion animal segment is forecast to grow at a CAGR of 5.6%.

Source: https://www.globenewswire.com/news-release/2021/06/14/2246688/0/en/Animal-Vaccines-Market-Size-To-Reach-13-78-Billion-By-2028-Allied-Market-Research.html


Like0
Dislike0
  • Please enter a comment


Name *
Email address *
Comment *


* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.


I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies



More news

Zoetis is Redefining the Feline Veterinary Experience with the Commercial Launch of Bonqat® (pregabalin oral solution) in the U.S.

Like0
Dislike0

Spatio-temporal patterns of tick-borne disease diagnoses in Indiana, USA (2009–2018)

Like0
Dislike0

Abdominal ultrasonographic findings of cats with feline infectious peritonitis: an update

Like0
Dislike0

Pseudohyperkalemia in horses with rhabdomyolysis reported by an enzymatic chemistry analyzer

Like0
Dislike0

Retrospective evaluation of prognosis and survival with various immunosuppressants in 82 dogs diagnosed with meningoencephalitis of unknown etiology (2010-2021).

Like0
Dislike0

Newsletter

 
 

News of interest

EVENTS

Copyright © 2024 - All Rights Reserved
ISSN 2768-198X

Top